Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients, \>/= 18 years of age
stage IIIB/IV recurrent or refractory non-small cell lung cancer
at most 2 lines of prior therapy in the metastatic setting (first line: platinum containing regimen and bevacizumab; second line: EGFR-targeted therapy)
ECOG performance status 0-2
adequate liver, renal and bone marrow function
You may not be if
prior chemotherapy or radiotherapy \</= 4 weeks before first dose of study drug
history of other malignancy within the past 2 years, except for basal cell skin carcinoma or in situ cervical carcinoma
history of CNS metastases or leptomeningeal metastases, except for clinically stable disease
